MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202647065128 A) filed by Biocells Beijing Biotech Co. , Ltd. on May 23, 2026, for Sulfonylurea Derivative And Use Thereof.
Inventors include Han, Huamin; and Ji, Qi.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present application relates to a sulfonylurea derivative or a pharmaceutically acceptable salt thereof and a use thereof. In particular, the present application relates to the use of the sulfonylurea derivative or the pharmaceutically acceptable salt thereof as an NLRP3 inflammasome inhibitor, wherein the structure of the sulfonylurea derivative is represented by formula I, wherein the definition of each substituent is detailed in the description.
Disclaimer: Curated by HT Syndication.
